Hisataka Kobayashi Selected Research

quinone (benzoquinone)

9/2017	Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1).
1/2017	A Near-Infrared, Wavelength-Shiftable, Turn-on Fluorescent Probe for the Detection and Imaging of Cancer Tumor Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisataka Kobayashi Research Topics

Disease

200	Neoplasms (Cancer) 04/2024 - 01/2002
26	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 07/2006
21	Neoplasm Metastasis (Metastasis) 04/2023 - 09/2006
10	Breast Neoplasms (Breast Cancer) 09/2022 - 05/2004
7	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024 - 01/2021
5	Necrosis 01/2020 - 01/2002
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 10/2017
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2016
4	Acute Kidney Injury (Acute Renal Failure) 01/2006 - 04/2004
3	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2015
3	Melanoma (Melanoma, Malignant) 01/2022 - 07/2007
3	Infections 01/2020 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019 - 07/2015
3	Carcinogenesis 01/2017 - 11/2007
3	Lymphatic Metastasis 01/2016 - 05/2004
3	Ischemia 01/2006 - 07/2003
2	Pain (Aches) 10/2023 - 04/2023
2	Edema (Dropsy) 10/2023 - 10/2021
2	Carcinoma (Carcinomatosis) 06/2018 - 01/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 11/2016
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2009

Drug/Important Bio-Agent (IBA)

57	Monoclonal AntibodiesIBA 08/2022 - 02/2002
31	AntibodiesIBA 04/2024 - 05/2007
31	Coloring Agents (Dyes)IBA 01/2023 - 11/2006
23	ErbB Receptors (EGF Receptor)IBA 12/2023 - 04/2007
22	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 11/2011
20	phthalocyanineIBA 01/2023 - 11/2011
19	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2008
19	Contrast MediaIBA 11/2016 - 01/2002
18	Therapeutic UsesIBA 04/2024 - 09/2003
18	AntigensIBA 11/2022 - 02/2002
18	Trastuzumab (Herceptin)FDA Link 01/2021 - 02/2002
17	AvidinIBA 12/2011 - 01/2003
15	RhodaminesIBA 11/2018 - 11/2006
12	LigandsIBA 01/2023 - 07/2006
12	Fluorescent Dyes (Fluorescent Probes)IBA 11/2018 - 11/2006
10	Panitumumab (Vectibix)FDA Link 08/2022 - 11/2009
10	Galactose (Galactopyranose)FDA LinkGeneric 11/2016 - 09/2007
10	Dendrimers (Dendrons)IBA 07/2011 - 09/2003
8	Cetuximab (Erbitux)FDA Link 08/2022 - 04/2007
8	EnzymesIBA 11/2018 - 08/2013
7	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 07/2002
7	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 02/2009
7	LuciferasesIBA 01/2020 - 07/2007
6	Neoplasm Antigens (Tumor Antigens)IBA 12/2023 - 01/2019
6	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2019
6	Red Fluorescent ProteinIBA 01/2018 - 11/2007
6	LectinsIBA 11/2016 - 07/2006
6	Indicators and Reagents (Reagents)IBA 07/2014 - 08/2008
6	GadoliniumIBA 04/2006 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2005
5	silicon phthalocyanineIBA 01/2023 - 11/2018
5	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2019 - 09/2006
5	Serum AlbuminIBA 11/2016 - 09/2007
4	Interleukin-15 (Interleukin 15)IBA 10/2023 - 01/2005
4	Epidermal Growth Factor (EGF)IBA 11/2022 - 11/2007
4	Immunoglobulin FragmentsIBA 10/2022 - 03/2011
4	Green Fluorescent ProteinsIBA 01/2017 - 11/2006
4	GalactosamineIBA 08/2008 - 09/2007
3	Surface Antigens (Surface Antigen)IBA 10/2022 - 06/2009
3	Immunotoxins (Immunotoxin)IBA 01/2020 - 08/2014
3	Immunoglobulin G (IgG)IBA 01/2017 - 04/2014
3	galactosyl serum albumin-rhodamine greenIBA 03/2014 - 11/2007
3	Growth Factor ReceptorsIBA 08/2012 - 03/2009
3	ferric oxide (iron oxide)IBA 03/2012 - 07/2011
3	Radioisotopes (Radionuclides)IBA 11/2009 - 09/2003
3	neutravidinIBA 01/2009 - 09/2006
3	Fluorescein (Funduscein)FDA LinkGeneric 09/2007 - 07/2006
2	Immune Checkpoint ProteinsIBA 04/2024 - 09/2020
2	SolutionsIBA 04/2023 - 04/2018
2	Silicon Dioxide (Silica)FDA LinkGeneric 06/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2020
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021 - 11/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 11/2011
2	AlbuminsIBA 01/2020 - 09/2017
2	ExotoxinsIBA 01/2020 - 08/2014
2	MesothelinIBA 01/2020 - 04/2016
2	human ERBB2 proteinIBA 01/2019 - 01/2017
2	GalactosidasesIBA 11/2018 - 03/2015
2	quinone (benzoquinone)IBA 09/2017 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 09/2017 - 01/2017
2	NAD (NADH)IBA 09/2017 - 01/2017
2	IsoenzymesIBA 09/2017 - 01/2017
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 01/2009
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 03/2003

Therapy/Procedure

85	Therapeutics 04/2024 - 02/2004
15	Immunotherapy 04/2024 - 01/2013
10	Phototherapy (Light Therapy) 11/2022 - 01/2015
8	Drug Therapy (Chemotherapy) 09/2022 - 11/2011
8	Lasers (Laser) 04/2022 - 01/2002
4	Precision Medicine 01/2017 - 03/2012
3	Radiotherapy 04/2023 - 09/2003
3	Molecular Targeted Therapy 09/2022 - 03/2012
3	Quantum Dots (Quantum Dot) 01/2016 - 06/2009
3	Neutron Capture Therapy 12/2005 - 01/2003
3	Radioimmunotherapy 12/2005 - 01/2003
2	Intravenous Injections 01/2023 - 12/2019
2	Aftercare (After-Treatment) 10/2021 - 01/2020